1.
Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models. jkcvhl [Internet]. 2025 Sep. 26 [cited 2026 Apr. 27];12(3):58-65. Available from: https://mail.jkcvhl.com/index.php/jkcvhl/article/view/427